1007455-28-8 Usage
Description
Methyl 6-bromo-2-fluoro-3-methoxybenzoate is a chemical compound with the molecular formula C9H7BrFO3. It is a derivative of benzoic acid and belongs to the class of organic compounds known as benzoic acid esters. Methyl 6-bromo-2-fluoro-3-methoxybenzoate is synthesized by replacing some hydrogen atoms with bromine, fluorine, and methoxy groups on the benzene ring, resulting in a versatile intermediate for various applications in chemical research and organic synthesis.
Uses
Used in Pharmaceutical Industry:
Methyl 6-bromo-2-fluoro-3-methoxybenzoate is used as an intermediate in the synthesis of pharmaceuticals for its ability to be modified and incorporated into a wide range of drug molecules. Its unique combination of functional groups allows for the development of new medications with specific therapeutic properties.
Used in Agrochemical Industry:
In the agrochemical sector, Methyl 6-bromo-2-fluoro-3-methoxybenzoate is utilized as an intermediate in the production of various agrochemicals. Its structural features make it suitable for the creation of compounds that can be used in pest control, crop protection, and other agricultural applications.
Used in Chemical Research:
Methyl 6-bromo-2-fluoro-3-methoxybenzoate is also employed in chemical research as a building block for the development of new organic compounds. Its presence in the synthesis process can lead to the discovery of novel materials with unique chemical properties and potential applications in various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 1007455-28-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,0,7,4,5 and 5 respectively; the second part has 2 digits, 2 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1007455-28:
(9*1)+(8*0)+(7*0)+(6*7)+(5*4)+(4*5)+(3*5)+(2*2)+(1*8)=118
118 % 10 = 8
So 1007455-28-8 is a valid CAS Registry Number.
1007455-28-8Relevant articles and documents
QUINAZOLINE DERIVATIVES AS ANTITUMOR AGENTS
-
, (2020/04/25)
The present application relates to novel quinazoline compounds as inhibitors of type I receptor tyrosine kinases, the pharmaceutical compositions comprising one or more of the compounds and salts thereof as an active ingredient, and the use of the compounds and salts thereof in the treatment of hyperproliferative diseases, such as cancer and inflammation, in mammals and especially in humans.
1H-PYRAZOLO [3, 4-B] PYRIDINE COMPOUNDS FOR INHIBITING RAF KINASE
-
Page/Page column 46, (2011/04/14)
Compounds of Formula I are useful for inhibition of Raf kinases. Methods of using compounds of Formula I and stereoisomers, tautomers and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed. [FORMULA I]
ISOINDOLE DERIVATIVES
-
Page/Page column 31; 32, (2010/11/30)
This invention relates to compounds of formula (I) or pharmaceutically acceptable salts thereof, a process of making these compounds, pharmaceutical compositions containing one or more of these compounds or their salts, and their use for the treatment of schizophrenia, bipolar disorder, or other central nervous system disorders.
